Načítá se...

Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial.

A randomised double-blind trial of (+)-cyanidanol-3(Catechin), 2 g/day versus placebo, was carried out in 40 patients with pre-cirrhotic alcohol-related liver disease over a three month period. Twenty received the active drug and 20 placebo; one non-compliant patient in the treatment group was withd...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Colman, J C, Morgan, M Y, Scheuer, P J, Sherlock, S
Médium: Artigo
Jazyk:Inglês
Vydáno: 1980
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1419277/
https://ncbi.nlm.nih.gov/pubmed/6108901
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!